Human ADAM DEC1 (ADAMDEC1) Protein

Este producto es parte de ADAMDEC1 - ADAM Like Decysin 1
Product Graph
273€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human ADAM DEC1 (ADAMDEC1) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx690102
tested applications
SDS-PAGE

Description

ADAM DEC1 (ADAMDEC1) protein is a recombinant Human protein expressed in HEK293 cells.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
ADAM DEC1 (ADAMDEC1)
Host
HEK293 cells
Assay Type
Activity: Not tested
Sequence Fragment: Lys206-Glu470
Tag: C-terminal 6 His tag
Origin
Human
Observed MW
Calculated MW: 30.3 kDa  Observed MW (SDS-PAGE): 33-41 kDa
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Purification
0.2 µm filtered.
Size 1
10 µg
Size 2
50 µg
Form
Liquid
Tested Applications
SDS-PAGE
Buffer
20 mM Tris-HCl, 150 mM NaCl, pH 7.5.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Shelf Life: 6 months.
Dry Ice
No
UniProt ID
O15204
Gene ID
27299
OMIM
606393
Alias
ADAM DEC1
Background
Protein ADAMDEC1
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Endotoxin Level: < 1.0 EU per µg (LAL method).

Descripción

ADAM Like Decysin 1 (ADAMDEC1) is a member of the ADAM (a disintegrin and metalloprotease) family of proteins, which are involved in proteolysis and cell-cell or cell-matrix interactions. Unlike most ADAM proteins, ADAMDEC1 lacks a transmembrane domain, making it a secreted protein. It is primarily expressed in immune-related tissues, such as lymph nodes, the colon, and macrophages, where it is thought to participate in immune response regulation and extracellular matrix remodeling. ADAMDEC1 is involved in degrading extracellular matrix proteins, potentially playing a role in inflammation, tissue remodeling, and immune surveillance. Dysregulation of ADAMDEC1 has been associated with inflammatory conditions and cancer, where altered extracellular matrix remodeling contributes to tumor invasion and metastasis. Emerging research focuses on its role in modulating immune cell activity and its potential as a biomarker or therapeutic target in inflammatory and oncological diseases.

Related Products

EH5175

Human ADAMDEC1 ELISA Kit

Ver Producto
FNab00145

ADAMDEC1 antibody

May play an important role in the control of the immune response and during pregnancy.

Ver Producto
Pr22281

Recombinant Human ADAMDEC1

Ver Producto